Clinical outcomes of combination treatment of teriparatide and denosumab for patients with osteoporotic vertebral factures

Clinical outcomes of combination treatment of teriparatide and denosumab for patients with osteoporotic vertebral factures - Clinical outcomes of combination treatment of teriparatide and denosumab for patients with osteoporotic vertebral factures

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016809

Enrollment

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporotic vertebral factures

Interventions

combination treatment of teriparatide and denosumab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients older than 65 years and with a fresh OVF

Exclusion criteria

Exclusion criteria: artificial dialysis dementia

Design outcomes

Primary

Measure	Time frame
XP, ADL and QOL at 6 months after osteoporotic vertebral factures	—

Countries

Japan

Contacts

Public ContactTomiya Matsumoto

Osaka Rosai Hospital orthopaedics

spap44d9@bird.ocn.ne.jp0722-52-3561

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026